Paxlovid

Company snapshot

Paxlovid is a pharma organization headquartered in NEW YORK, NY, JP. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 193 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• 193 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Paxlovid. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Paxlovid.

1. Jul 22, 2025 Patent grant

   Injectable scaffold for treatment of intracranial aneurysms and related technology

2. Jul 15, 2025 Patent grant

   Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer

3. Jun 24, 2025 Patent grant

   Cancer therapeutic compositions and methods targeting DNAse1L3

4. Jun 17, 2025 Patent grant

   Airway management systems for pulmonary disorder treatment

5. Apr 29, 2025 Patent grant

   Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders

View all clinical trial activity →

• What is Paxlovid?

  Paxlovid is a pharma organization headquartered in NEW YORK, NY, JP. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 193 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• Is Paxlovid publicly traded?

  Paxlovid appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Paxlovid develop or market?

  No drug profiles are currently linked to Paxlovid. Pipeline programs may still list investigational assets.

• What are the latest developments for Paxlovid?

  In the last 12 months our linked public records show 0 trial program update(s) and 4 US patent grant(s) tied to this profile.

• What therapeutic areas does Paxlovid focus on?

  No specific therapeutic focus areas are currently identified for Paxlovid in our database.